drugset / Trial / NCT01865721

Optimizing the Use of Entonox® During Screening Colonoscopy

NCT01865721

Phase 4 Completed 100 enrolled Sheffield Teaching Hospitals NHS Foundation Trust
RandomizedParallel-groupOpen-labelTreatment

Summary

This study will randomise patients undergoing screening colonoscopy to receive Entonox either continuously or as required. Both these methods are used in the published studies of Entonox and in clinical practice. Null hypothesis There will be no difference in pain levels between these two methods of Entonox administration

Timeline

Start
2013-01
Primary completion
2014-04
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Entonox Unknown Inhaled

Indications

No indication recorded.